Template:Pulmonary Disorders and COVID-19: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 10: Line 10:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Acute respiratory distress syndrome|Acute respiratory distress syndrome]]
[[COVID-19 Pulmonary Complications#Acute respiratory distress syndrome|Acute respiratory distress syndrome]]
|-  
|-  
!
!
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Pneumonia|Pneumonia]]
[[COVID-19 Pulmonary Complications#Pneumonia|Pneumonia]]
|-  
|-  
!
!
Line 22: Line 22:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Pulmonary embolism|Pulmonary embolism]]
[[COVID-19 Pulmonary Complications#Pulmonary embolism|Pulmonary embolism]]
|-  
|-  
!
!
Line 28: Line 28:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Hypoxemia|Hypoxemia]]
[[COVID-19 Pulmonary Complications#Hypoxemia|Hypoxemia]]
|-  
|-  
!
!
Line 34: Line 34:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Superinfection|Superinfection]]
[[COVID-19 Pulmonary Complications#Superinfection|Superinfection]]
|-  
|-  
!
!
Line 40: Line 40:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Pulmonary hypertension|Pulmonary hypertension]]
[[COVID-19 Pulmonary Complications#Pulmonary hypertension|Pulmonary hypertension]]
|-  
|-  
!
!
Line 46: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Respiratory failure|Respiratory failure]]
[[COVID-19 Pulmonary Complications#Respiratory failure|Respiratory failure]]
|-  
|-  
!
!
Line 52: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Pulmonary Disorders and COVID-19#Increased mortality in COPD patients|Increased mortality in COPD patients]]
[[COVID-19 Pulmonary Complications#Increased mortality in COPD patients|Increased mortality in COPD patients]]
|-  
|-  
!
!

Latest revision as of 01:51, 24 June 2020